Content Table
The 5th annual Bronchiectasis Patient Conference will take place from 10:00 to 16:00 CET on 15 March 2025. It is organised in collaboration with EMBARC and our Bronchiectasis Patient Advisory Group (PAG).
The event will cover topics including:
We will hear from people living with bronchiectasis and healthcare professionals. You can ask questions to the speakers and experts via the chat.
The complete programme for the event will be added soon.
The conference will be held in English. A live transcription service will be provided that can generate captions in over 60 languages.
More speakers will be added once they are confirmed.
Professor James Chalmers is the British Lung Foundation Chair of Respiratory Research at the University of Dundee, UK, and a consultant respiratory physician.
He is an expert in lung infections and has been involved in a number of projects during the COVID-19 pandemic, including leading the ERS Guidelines Task Force for COVID-19 and being chief investigator for several trials of new COVID-19 treatments.
He works closely with ELF to involve patients in respiratory infection research through projects such as EMBARC, and is an advocate for involving patients in guidelines, clinical research, and clinical trials.
Michal Shteinberg received her MD and a PhD in biochemistry from the Technion-Israel institute of technology. She trained in internal medicine and pulmonology, with a Fellowship in bronchiectasis and adult CF.
Prof. Shteinberg is Head of Bronchiectasis and Adult Cystic Fibrosis Unit, Carmel Medical Center, and the Technion - Israel Institute of Technology, the B. Rappaport Faculty of Medicine, Haifa, Israel.
She is a Clinical Associate Professor in the Faculty of medicine at the Technion, Israel Institute of Technology, and a member of the executive committee of the Israeli Society for Tuberculosis and mycobacterial diseases.
Her main research interests are bronchiectasis and its overlap with other airway diseases, mainly rhinosinusitis, and connective tissue diseases, as well as adult CF.
Prof. Shteinberg is a member of EMBARC management and heading Patient Activities Work package.
Dr Pieter Goeminne is a respiratory physician in Saint-Nicholas, Belgium.
His PhD defence was in non-cystic fibrosis bronchiectasis. He is co-author of many publications on the topic of bronchiectasis, such as the ERS bronchiectasis guidelines.
He is also Board member of the European bronchiectasis registry EMBARC and regular reviewer for high impact journals on bronchiectasis. His further professional interests include air pollution and infectious disease.
This event is developed with and supported by EMBARC, a pan-European network and the ELF Bronchiectasis Patient Advisory Group.
This is the fifth instalment of our annual bronchiectasis patient conference. Watch the recordings from our previous events below.
ELF does not charge for its events and materials. We want to make sure they are available to anybody who wishes to join or use them. To ensure we can keep doing this we ask that those who can afford to pay to make a donation. We are grateful to everyone who supports us in this way and helps lung health patients to understand more about their condition and have their voices heard.
